image
bluebird bio, Inc. BLUE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.77
-3.64 %
$ 46.7 M
Market Cap
-0.19
P/E
Price Target Average
109.64%
Revenue Forecast Estimate
49.17%
EBIT Estimate
--11.30%
Net Income Estimate
63.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets bluebird bio, Inc.
image
Wall Street analysts predict an average 1-year price target for BLUE of $10 , with forecasts ranging from a low of $5 to a high of $14 .
BLUE Lowest Price Target Wall Street Target
5 USD 4.82%
BLUE Average Price Target Wall Street Target
10 USD 109.64%
BLUE Highest Price Target Wall Street Target
14 USD 193.50%
Price
Max Price Target
Min Price Target
Average Price Target
303025252020151510105500May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart BLUE

image
$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart BLUE

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart BLUE

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029